The Luxembourgish Tumor Immunotherapy and Microenvironment (TIME) group has found a way to enhance immunotherapy when treating cancer. Their double attack on tumors has shown to significantly shrink them and improve survival rates.
What's right: gut bacteria can enhance cancer immunotherapy.
A specific strain of gut bacteria, Ruminococcus Gnavus, can enhance the efficacy of cancer immunotherapy. Tumors in mice shrank once researchers introduced Ruminococcus Gnavus to mice.
What's right: one year cancer-free after personally developed treatment.
An Australian doctor has remained brain cancer-free for a year after being the first patient to undergo a type of immunotherapy treatment that he himself developed.